Gregory Philip D 4
4 · 2seventy bio, Inc. · Filed May 5, 2022
Insider Transaction Report
Form 4
Gregory Philip D
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to buy)
2022-03-01+95,000→ 95,000 totalExercise: $13.41Exp: 2032-03-01→ Common Stock (95,000 underlying) - Award
Common Stock
2022-03-01+47,500→ 109,160 total
Footnotes (2)
- [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/01/2023, 25% on 01/01/2024, 25% on 01/01/2025, and 25% on 01/01/2026.
- [F2]This stock option vests over a four-year period at the rate of 25% on 01/01/2023 and then in 36 equal monthly installments thereafter.